Mechano‐targeted interventions, including the use of fibronectin‐binding drug conjugates or imaging tracers like FnBPA5,[68, 110] may offer novel strategies to selectively target the tumor microenvironment and enhance the effectiveness of immunotherapies. Here, FN1 is linked to neoplasm.